Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group

Lieke H. J. Simkens, Harm van Tinteren, Anne May, Albert J. ten Tije, Geert-Jan M. Creemers, Olaf J. L. Loosveld, Felix E. de Jongh, Frans L. G. Erdkamp, Zoran Erjavec, Adelheid M. E. van der Torren, Jolien Tol, Hans J. J. Braun, Peter Nieboer, Jacobus J. M. van der Hoeven, Janny G. Haasjes, Rob L. H. Jansen, Jaap Wals, Annemieke Cats, Veerle A. Derleyn, Aafk E. H. HonkoopLinda Mol, Cornelis J. A. Punt, Miriam Koopman

Research output: Contribution to journalArticleAcademicpeer-review

85 Citations (Scopus)
Original languageEnglish
Pages (from-to)1843-1852
JournalLancet
Volume385
Issue number9980
DOIs
Publication statusPublished - 9 May 2015

Cite this

Simkens, L. H. J., van Tinteren, H., May, A., ten Tije, A. J., Creemers, G-J. M., Loosveld, O. J. L., de Jongh, F. E., Erdkamp, F. L. G., Erjavec, Z., van der Torren, A. M. E., Tol, J., Braun, H. J. J., Nieboer, P., van der Hoeven, J. J. M., Haasjes, J. G., Jansen, R. L. H., Wals, J., Cats, A., Derleyn, V. A., ... Koopman, M. (2015). Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group. Lancet, 385(9980), 1843-1852. https://doi.org/10.1016/S0140-6736(14)62004-3